Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Tranilast
Cat. No.:
0225LY-1133
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Tranilast is an antiallergic medication that treats allergic conditions by suppressing the release of cytokines and lipid mediators from inflammatory cells.
Synonym:
MK 341; SB 252218; 53902-12-8; Trans-Tranilast; Rizaben; Tranilastum; N-(3,4-Dimethoxycinnamoyl)anthranilic acid; MK-341; Tranilast (trans-); SB-252218; (E)-2-(3-(3,4-dimethoxyphenyl)acrylamido)benzoic acid; 2-[[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino]benzoic acid; 2-((3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid; 2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid; 2-{[(2e)-3-(3,4-Dimethoxyphenyl)prop-2-Enoyl]amino}benzoic Acid; (E)-2-[[3-(3,4-Dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid
CAS No.:
53902-12-8
Compound CID:
5282230
Formula:
C18H17NO5
Formula Weight:
327.33
Specification
Targets&IC50:
PGD2: 0.1 mM (IC50)
Relative Density:
1.299 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Tranilast can be used in fibrosis research to study the inhibition of collagen synthesis and TGF-beta signaling.
Library Information
Target:
Angiotensin receptor; Prostaglandin receptor
Receptor:
Angiotensin receptor; Prostaglandin receptor
Pathways:
Immunology/Inflammation; GPCR/G protein signaling; Endocrinology/Hormones
Plate Number:
AOCL-15
Plate Location:
e9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
250 mg/mL; 763.76 mM





